Latest Whitepapers

This whitepaper explores the regulatory environment surrounding data integrity, and what to look for in a laboratory information management system (LIMS) to ensure compliance.

This whitepaper explores groundbreaking organ-on-a-chip technology and 3D tissue modeling that is closing the translational gap in cancer drug discovery.

This whitepaper explores the need for transparency between suppliers and manufacturers, ensuring the integrity of their products and maintaining trust among consumers and regulatory authorities alike.

In this paper, we demonstrate how the GeneArt Gibson Assembly EX Cloning Kit can be used to make very large constructs using up to 10 inserts. We also compare this kit to the Invitrogen™ GeneArt™ Seamless Cloning Kit and another supplier’s product.

In this paper, we demonstrate how the GeneArt Gibson Assembly HiFi Cloning Kit can be used with multiple Invitrogen™ GeneArt™ Strings DNA Fragments to produce large constructs in highly efficient reactions.

This whitepaper explores three unique case studies, showing how TEMs can be applied in diagnostics. Learn how to fine tune pore size and density to reliably capture target cells, ensure quality manufacturing and benefit downstream analysis.

This whitepaper explores the advantages of a novel cell sorting and dispensing platform – which combines microfluidics, flow cytometry and liquid dispensing – that can help researchers get to their optimal clones more efficiently.

This article explores how we can find new ways to stop tumor growth and prevent drug resistance by targeting the language of cancer cell communication.

As biopharmaceutical companies scale up manufacturing, many are turning to outsourcing for buffer and process liquid preparation. But before making this decision, organizations must carefully weigh up various factors, including manufacturing space, personnel requirements and analytical capabilities.

This whitepaper explores methods and reagents available to evaluate drug specificity and effectiveness.